Tag Archives: News

‘Poop pill’ capsule research paves the way for simpler C. difficile treatment

An Alberta-led clinical trial has shown Fecal Microbiota Transplant (FMT) is effective in treating clostridium difficile (C. difficile) infections whether delivered by colonoscopy or by swallowing capsules. The finding, published in the Journal of the American Medical Association, could revolutionize and broaden the use of FMT, which restores the healthy balance of bacteria living in the intestine by transferring a ...

Read More »

Racial disparities persist in the survival of patients with ovarian, colon, and breast cancer

Three new articles present trends in survival for patients with ovarian, colon, and breast cancer in the United States by race and stage. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings reveal large, consistent, and persistent racial disparities in survival. For the analyses, a team led by investigators at the Centers for Disease ...

Read More »

Finding a less poopy solution for fecal transplant regulation

As fecal matter transplants (FMTs) continue to be more widely adopted, it is critical to have an appropriate regulatory framework in place, authors of this Policy Forum emphasize. They go on to outline key areas for improvement, compared to current regulatory approaches. The transfer of stool from one healthy donor to a recipient for re­current Clostridium difficile infection (CDI) is ...

Read More »

New protocol leads to significant drop in prescription narcotic use among colorectal surgery patients

A quality improvement initiative has led to a significant drop in narcotic pain medications prescribed to patients who undergo colorectal surgery at UF Health Shands Hospital in Gainesville, Florida. “Fewer patients are receiving oral narcotics during their hospital stay. More importantly, we are discharging even fewer patients with prescriptions for narcotic pain medication. Often, patients become addicted after taking legally ...

Read More »

Gastric cancer: A new strategy used by Helicobacter pylori to target mitochondria

Helicobacter pylori is a bacterial pathogen that colonizes the stomach of approximately half of the world’s population. Infection with H. pylori is acquired in childhood and lasts for decades. H. pylori is the main risk factor for gastric cancer and is linked to more than 80 percent of cases. Gastric cancer, the third most common cause of cancer-related death, is ...

Read More »